Q32 Bio Inc. - ROE
QTTB
Price:
$11.9
Market Cap:
$152.04M
Operating as a clinical-stage biotechnology firm, Q32 Bio Inc. is dedicated to developing biologic therapies aimed at re-establishing healthy immune equilibrium in patients across the United States suffering from autoimmune and inflammatory disorders stemming from dysfunctional immune responses. The company's primary investigational therapy, ADX-097, is a humanized anti-C3d monoclonal antibody fusion protein designed to normalize complement regulation. This candidate has successfully finished its Phase I clinical trial, targeting severe renal and other complement-driven conditions where patient needs are largely unmet, such as lupus nephritis, IgA nephropathy, C3 glomerulopathy, and ANCA-ass...[Read more]
Industry
Biotechnology
IPO Date
2018-03-28
Stock Exchange
NASDAQ
Ticker
QTTB
PE Ratio
[4.28]
ROE
[230.68%]
Current Ratio
[5.36]
Dividend Yield
[0%]
Enterprise Value
[114.93M]
Dividend History
The ROE as of June 2026 (TTM) for Q32 Bio Inc. (QTTB) is 230.68%
According to Q32 Bio Inc.’s latest financial reports and current stock price. The company's current ROE is 230.68%. This represents a change of 286.74% compared to the average of 59.65% of the last 4 quarters.
Q32 Bio Inc. (QTTB) Historical ROE (quarterly & annually)
How has QTTB ROE performed in the past?
The mean historical ROE of Q32 Bio Inc. over the last ten years is -109.32%. The current 230.68% ROE has changed -311.01% with respect to the historical average. Over the past ten years (40 quarters), QTTB's ROE was at its highest in in the March 2025 quarter at 274.81%. The ROE was at its lowest in in the December 2024 quarter at -250.03%.
Average
-109.32%
Median
-35.35%
Minimum
-841.11%
Maximum
70.98%
Q32 Bio Inc. (QTTB) ROE by Quarter and Year
Discovering the peaks and valleys of Q32 Bio Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 63.34%
Maximum Annual ROE = 70.98%
Minimum Annual Increase = -2962.82%
Minimum Annual ROE = -841.11%
| Year | ROE | Change |
|---|---|---|
| 2025 | 70.98% | -108.44% |
| 2024 | -841.11% | -2962.82% |
| 2023 | 29.38% | -222.15% |
| 2022 | -24.05% | -57.39% |
| 2021 | -56.45% | -14.03% |
| 2020 | -65.66% | 63.34% |
| 2019 | -40.20% | 42.02% |
| 2018 | -28.30% | -7.22% |
| 2017 | -30.51% | -71.56% |
Q32 Bio Inc. (QTTB) Average ROE
How has QTTB ROE performed in the past?
The current ROE of Q32 Bio Inc. (QTTB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-246.92%
5-year avg
-164.25%
10-year avg
-109.32%
Q32 Bio Inc. (QTTB) ROE vs. Peers
How is QTTB’s ROE compared to its peers?
Q32 Bio Inc.’s ROE is greater than NextCure, Inc. (-186.96%), greater than Boundless Bio, Inc. (-53.60%), greater than SAB Biotherapeutics, Inc. (-0.29%), greater than AN2 Therapeutics, Inc. (-52.35%), greater than Verrica Pharmaceuticals Inc. (-1136.50%), greater than Plus Therapeutics, Inc. (-198.48%), greater than Generation Bio Co. (-94.82%), greater than Intensity Therapeutics, Inc. (-136.82%), less than Iterum Therapeutics plc (602.38%), greater than Sonnet BioTherapeutics Holdings, Inc. (-518.10%),
| Company | ROE | Market cap |
|---|---|---|
| -186.96% | $5.41M | |
| -53.60% | $32.12M | |
| -0.29% | $38.23M | |
| -52.35% | $137.01M | |
| -1136.50% | $59.97M | |
| -198.48% | $10.16M | |
| -94.82% | $35.98M | |
| -136.82% | $7.39M | |
| 602.38% | $1.60M | |
| -518.10% | $8.43M |
Build a custom stock screener for Q32 Bio Inc. (QTTB) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Q32 Bio Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Q32 Bio Inc. (QTTB) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Q32 Bio Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Q32 Bio Inc.'s ROE?
How is the ROE calculated for Q32 Bio Inc. (QTTB)?
What is the highest ROE for Q32 Bio Inc. (QTTB)?
What is the 3-year average ROE for Q32 Bio Inc. (QTTB)?
What is the 5-year average ROE for Q32 Bio Inc. (QTTB)?
How does the current ROE for Q32 Bio Inc. (QTTB) compare to its historical average?